Huarui Zhang

机构：Chinese University of Hong Kong, Westlake University · ORCID：0000-0001-5008-3447

发表论文 38 篇 · 总被引 804 次 · h-index 13

代表论文

• Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding (2023 · Frontiers in Cell and Developmental Biology · 被引 84)
• A bimolecular modification strategy for developing long-lasting bone anabolic aptamer (2023 · Molecular Therapy — Nucleic Acids · 被引 20)
• Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity (2024 · Nature Communications · 被引 18)
• Connective Tissue Growth Factor: Regulation, Diseases, and Drug Discovery (2024 · International Journal of Molecular Sciences · 被引 18)
• Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potential (2024 · Molecular Therapy — Nucleic Acids · 被引 18)
• Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy (2024 · Cancer Letters · 被引 15)